StonvexLoading…
StonvexStonvexStonvexCore line items from LASR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $261.33M | $198.55M | $209.92M | $242.06M |
Operating Income | $-26.55M | $-65.64M | $-46.77M | $-55.10M |
Net Income | $-23.47M | $-60.79M | $-41.67M | $-54.58M |
EPS (Diluted) | $-0.47 | $-1.27 | $-0.90 | $-1.23 |
Total Assets | $315.21M | $270.24M | $306.80M | $329.23M |
Total Liabilities | $88.46M | $53.81M | $52.38M | $58.39M |
Cash & Equivalents | $98.70M | $65.83M | $53.21M | $57.83M |
Free Cash Flow OCF − CapEx | $12.30M | $-10.29M | $4.75M | $-35.93M |
Shares Outstanding | 51.16M | 48.95M | 47.27M | 45.63M |